Multiple sclerosis patients treated with diroximel fumarate in the real-world setting have high rates of persistence and adherence

Authors
Category Primary study
JournalNeurology
Year 2021
This article has no abstract
Epistemonikos ID: 35d5171a3cc78ee3d62e830f0a48a99f07d4b440
First added on: Feb 13, 2025